产生针对VacA的导向,以增加针对Helicobacter pylori的特定抗微生物毒性
Patrick S Ortiz1, Mikaeel Young1, Toslim Mahmud1
1Baylor University, Department of Biology, 101 Bagby Ave., Waco, TX 76706, USA.
Journal of biotechnology
|March 29, 2025
概括
研究人员增强了抗微生物 (AMP) 以向H. pylori,通过将它们与通过菌体显示识别的针对VacA毒性因子的指导融合,增加了对胃癌病原体的特异性和有效性.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 药物发现 药物发现 药物发现
背景情况:
- 杆菌 (H. pylori) 毒性因子VacA和CagA是胃癌的关键驱动因素.
- 抗微生物 (AMP) 提供潜在的治疗益处,但往往缺乏特异性.
- 开发有针对性的抗微生物策略对于对抗H. pylori感染至关重要.
研究的目的:
- 增强抗菌对抗H.pylori的特异性和活性.
- 开发一种方法,使用菌体显示器快速生成目标.
- 改善AMP用于胃癌治疗的治疗窗口.
主要方法:
- 菌体显示生物扫描被用于识别向H. pylori VacA蛋白的类.
- 选择的被融入了抗菌性pexiganan,与指导和链接剂,以赋予特异性.
- 使用ELISA和细胞培养试验评估了对H. pylori和非标细胞的结合亲和和和差异性毒性.
主要成果:
- 菌体显示器成功识别了与H. pylori VacA.高结合亲和度的.
- 引导的融合到pexiganan显著增加了对H.pylori的毒性.
- 最佳配置,P5-pexiganan,表现出64至256倍的差异毒性和超过128倍的治疗窗口.
- 修改后的AMP减少了非目标毒性.
结论:
- 导向生物测试是一种有效和可扩展的方法来提高AMP的特异性.
- 针对 VacA 等关键毒性因子,可以显著提高 AMP 对 H. pylori 的疗效.
- 这一战略对开发针对胃癌的新疗法充满希望.
相关概念视频
Antibiotic Selection
48.9K
Overview
48.9K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K
Peptic Ulcer
48
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
48
Inhibitors of Gram-positive Cell Wall Synthesis
191
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191
Gastritis II: Pathophysiology
52
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52
Peptic Ulcer Disease II: Pathophysiology
44
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
44


